Rhamnopyranoside-Based Fatty Acid Esters as Antimicrobials: Synthesis, Spectral Characterization, PASS, Antimicrobial, and Molecular Docking Studies
Authors:
- Abul Fazal Muhammad SanaullahASAbul Fazal Muhammad Sanaullah
- Puja DeviPuja Devi
- Takbir HossainTHTakbir Hossain
- Sulaiman Bin SultanSulaiman Bin Sultan
- Mohammad Mohib Ullah BadhonMBMohammad Mohib Ullah Badhon
- Emdad HossainEHEmdad Hossain
- Jamal UddinJUJamal Uddin
- Abdul Majed PatwaryAbdul Majed Patwary
- Mohsin KaziMohsin Kazi
- Mohammed Mahbubul MatinMohammed Mahbubul Matin
Open Access
Abstract
The most widely used and accessible monosaccharides have a number of stereogenic centers that have been hydroxylated and are challenging to chemically separate. As a result, the task of regioselective derivatization of such structures is particularly difficult. Considering this fact and to get novel rhamnopyranoside-based esters, DMAP-catalyzed di-O-stearoylation of methyl α-l-rhamnopyranoside (3) produced a mixture of 2,3-di-O- (4) and 3,4-di-O-stearates (5) (ratio 2:3) indicating the reactivity of the hydroxylated stereogenic centers of rhamnopyranoside as 3-OH > 4-OH > 2-OH. To get novel biologically active rhamnose esters, di-O-stearates 4 and 5 were converted into six 4-O- and 2-O-esters 6–11, which were fully characterized by FT-IR, 1H, and 13C NMR spectral techniques. In vitro antimicrobial assays revealed that fully esterified rhamnopyranosides 6–11 with maximum lipophilic character showed better antifungal susceptibility than antibacterial activity. These experimental findings are similar to the results found from PASS analysis data. Furthermore, the pentanoyl derivative of 2,3-di-O-stearate (compound 6) showed better antifungal functionality against F. equiseti and A. flavus, which were found to be better than standard antibiotics. To validate the better antifungal results, molecular docking of the rhamnose esters 4–11 was performed with lanosterol 14α-demethylase (PDB ID: 3LD6), including the standard antifungal antibiotics ketoconazole and fluconazole. In this instance, the binding affinities of 10 (−7.6 kcal/mol), 9 (−7.5 kcal/mol), and 7 (−6.9 kcal/mol) were better and comparable to fluconazole (−7.3 kcal/mol), indicating the likelihood of their use as non-azole type antifungal drugs in the future.Keywords
Funding Information
- Ministry of Science and Technology, Bangladesh (SRG-226639, RSP2023R301)
- King Saud University, Riyadh, Saudi Arabia (SRG-226639, RSP2023R301)
This publication has 45 references indexed in Scilit:
- Sugar Fatty Acid Esters2015
- Prediction of the Biological Activity Spectra of Organic Compounds Using the Pass Online Web ResourceChemistry of Heterocyclic Compounds, 2014
- Analgesic activity ofEugenia jambolanaleave constituent: A dikaempferol rhamnopyranoside from ethyl acetate soluble fractionPharmaceutical Biology, 2014
- Sucrose esters as natural surfactants in drug delivery systems—A mini-reviewInternational Journal of Pharmaceutics, 2012
- Glucose–aspirin: Synthesis and in vitro anti-cancer activity studiesBioorganic & Medicinal Chemistry Letters, 2012
- Antibacterial and synergy of a flavanonol rhamnoside with antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA)Phytomedicine, 2011
- Sucrose monolaurate improves the efficacy of sodium hypochlorite against Escherichia coli O157:H7 on spinachInternational Journal of Food Microbiology, 2011
- Structural Basis of Human CYP51 Inhibition by Antifungal AzolesJournal of Molecular Biology, 2010
- Regioselective one-pot protection of carbohydratesNature, 2007
- Selective sulfonylation of 4-C-hydroxymethyl-β-l-threo-pento-1,4-furanose: synthesis of bicyclic diazasugarsTetrahedron, 2004